Drug profile · INN
idursulfase
ELAPRASE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
idursulfase (ELAPRASE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda. Route of administration: iv (infusion). Current US regulatory status: approved.
Key facts
INN idursulfase
Brand ELAPRASE
Route IV (INFUSION)
Formulation INJECTABLE
ATC code A16AB09
Originator Takeda
Frequently asked questions
What is idursulfase?
idursulfase (ELAPRASE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda. Route of administration: iv (infusion). Current US regulatory status: approved.
What is the brand name for idursulfase?
ELAPRASE is a marketed brand name for idursulfase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of idursulfase?
idursulfase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.